Low Prevalence of High-dose Methotrexate Nephropathy in Patients With Malignancy
Iranian Journal of Kidney Diseases, 03/05/2012Ali Mashhadi M et al.
The data revealed a low prevalence of acute kidney injury with high–dose methotrexate therapy. In addition, these toxicities were limited to the first and second phases of the RIFLE classification, all of which resolved spontaneously.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.